[Abstract] Escherichia coli (E. coli) produces disseminated infections of the urinary tract, blood, and central nervous system where it encounters professional phagocytes such as macrophages, which utilize reactive nitrogen intermediates (RNI) to arrest bacteria. In vitro, extraintestinal pathogenic E. coli (ExPEC) can survive within bone marrow-derived macrophages for greater than 24 h post-infection within a LAMP1+ vesicular compartment, and ExPEC strains, in particular, are better adapted to intracellular macrophage survival than commensal strains (Bokil et al., 2011) . 11. 1% Triton-X 100 (see Recipes) 12. RAW 264.7 media (DMEM + 10% FBS) (see Recipes)
1 M L-arginine stock solution (see Recipes)
14. 1M L-NAME stock Solution (see Recipes) Equipment 1. 24 well tissue culture trays 2. Table-top 9. Centrifuge plates in a swinging bucket clinical centrifuge with microtray adaptors at low speed to bring bacteria in contact with the cell monolayer (5 min at 1,000 rpm) and then incubated for 1 h at 37 °C with 5% CO 2 .
10. Determine initial 1 h adherence/invasion for the various treatment groups by following steps m through p). This number will be used to normalize CFU/well at 24 h post-infection to account for any difference in initial adherence/invasion among the various treatment groups or bacterial strains (Note 6).
11. For the remainder of the treatment groups, wash infected monolayers 3 times with 0.5 mL PBS (avoid touching the monolayer with pipette tips or directly applying the wash onto the monolayer as this may disturb the integrity of the monolayer. This step is to remove the majority of extracellular bacteria).
12. Incubate for the remainder of the 24 h experiment using a step-down gentamicin protocol 
Treatment Groups and Controls Notes
1. UTI89 is a prototypic ExPEC cystitis isolate that was obtained from an adult patient with cystitis and has been well described in the literature (Mulvey, 1998) . Other ExPEC isolates can be used as well.
2. RAW 264.7 cells were purchased from the ATCC. coli infection.
